Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Colliers Reports First Quarter Results
-
AppSignal Closes $22 Million Growth Investment to Expand Reach in the Application Performance Monitoring Market
-
CareCloud Delivers Growth and Strong Cash Flow in Q1 2025, Advances AI and Acquisition Strategy
-
FAVO Capital Secures $8 Million Series A Preferred Investment from Stewards Investment Capital
-
Strategic Venue Partners Expands C-Suite with Industry Veteran David Tokunaga as COO
-
Cipher Mining Provides First Quarter 2025 Business Update
-
Datadog Announces First Quarter 2025 Financial Results
-
Inventus Announces Early Warrant Exercise by McEwen Mining and Begins Grade Control Drilling at Pardo
-
CECO Environmental Announces Upcoming Investor Conferences
-
Bitfarms Announces Participation in Upcoming Investor and Industry Conferences
-
GlobalFoundries Reports First Quarter 2025 Financial Results
-
TScan Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
-
Blue Point Brewing Co. Announces the Return of Delayed Pilsner
-
Reminder - Stella-Jones’ First Quarter Results Conference Call and Annual Meeting of Shareholders
-
Prairie Operating Co. Expands Senior Leadership Team
-
Beam Therapeutics Reports First Quarter 2025 Financial Results and Recent Business Highlights
-
Apellis Pharmaceuticals to Present at Upcoming Investor Conferences
-
Iterum Therapeutics to Report First Quarter 2025 Financial Results on May 13, 2025
-
Fractyl Health to Report First Quarter 2025 Financial Results and Provide Business Updates on May 13, 2025, and Will Participate in an Upcoming Investor Conference
-
EnteroBiotix Presents Positive IBS-C Data at Digestive Disease Week® 2025
-
Sitryx nominates SIT-047, a novel, oral MTHFD2 inhibitor, for clinical development in psoriatic arthritis
-
Optima Health to acquire Care first
-
Signify share repurchase period update
-
Topas Therapeutics’ TPM502 Achieves Gluten-specific Tolerance Induction, Positive Safety Profile in Phase 2a Trial in Celiac Disease Patients
-
Sharps Technology Receives ~$100K Initial Purchase Order from Hungarian Vaccine Provider for SecureGard™ Syringes
-
YieldMax™ ETFs Announces Distributions on BIGY ($0.4609) and SOXY ($0.4384)
-
RentRedi Launches “The Rental Pro” Newsletter to Help Landlords Grow Their Rental Businesses
-
ANOTHER STRONG START TO THE YEAR SUSTAINED BY PRODUCT MIX
-
TopBuild Reports First Quarter 2025 Results; Confirms Full Year Outlook
-
Brookfield Asset Management Announces Record First Quarter Results
-
Brazil Potash Announces Agreement for up to $75 Million Equity Line of Credit From Alumni Capital
-
Brilliant Earth Reports First Quarter 2025 Results
-
dsm-firmenich shareholders approve all resolutions at Annual General Meeting 2025
-
Probe Awards EIS Contract; Advances Permitting for Novador Project
-
Kraken Robotics Subsidiary 3D At Depth Completes 1,000th Subsea Metrology
-
Amesite Announces Successful Launch of New, Higher-Priced Tier of Service in Response to B2B Demand
-
Vivid Seats Reports First Quarter 2025 Results
-
PKP S.A.’s President: “Without cheap electricity, rail cannot compete with other modes of transportation.”
-
Holding(s) in Company
-
Dimensional Fund Advisors Ltd. : Form 8.3 - RENEWI PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - PRIMARY HEALTH PROPERTIES - Ordinary Shares
-
VPG Reports Fiscal 2025 First Quarter Results
-
Dimensional Fund Advisors Ltd. : Form 8.3 - LONDONMETRIC PROPERTY PLC - Ordinary Shares
-
Enlight Renewable Energy Reports First Quarter 2025 Financial Results
-
Ingredion Incorporated Reports Strong First Quarter Results and Improves Full-Year Outlook
-
Jitterbit Unveils Layered AI Architecture, Adds Accountable AI Agents to AI-Infused Low-Code Harmony Platform
-
Centerra Gold Announces Quarterly Dividend of C$0.07 per Common Share
-
Danske Bank A/S, transactions by persons discharging managerial responsibilities
-
Extend your time outdoors with Thermacell®’s new E65 Rechargeable Mosquito Repeller + Fast Charging Dock
-
Centerra Gold Reports First Quarter 2025 Results; Approved up to $75 Million to Repurchase Shares in 2025; Announces Updated Mineral Resource at Kemess and Advancing Studies on the Project

